Voyager Therapeutics (STU:VT6) Change In Other Working Capital : €-17.2 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Voyager Therapeutics Change In Other Working Capital?

Voyager Therapeutics's Change In Other Working Capital for the quarter that ended in Mar. 2024 was €-8.0 Mil. It means Voyager Therapeutics's Other Working Capital declined by €8.0 Mil from Dec. 2023 to Mar. 2024 .

Voyager Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €7.8 Mil. It means Voyager Therapeutics's Other Working Capital increased by €7.8 Mil from Dec. 2022 to Dec. 2023 .

Voyager Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Voyager Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyager Therapeutics Change In Other Working Capital Chart

Voyager Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

72.84

-118.82

-2.19

21.83

7.85

Voyager Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															17.29	-1.59	-1.10	-6.48	-8.01

Voyager Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-17.2 Mil.

Voyager Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Voyager Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyager Therapeutics (STU:VT6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Voyager Therapeutics Inc (STU:VT6) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

VYGR:USA

Address

64 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.voyagertherapeutics.com

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies.

Voyager Therapeutics (STU:VT6) Headlines

No Headlines